ABBVRGX-314 is under clinical development by AbbVie and currently in Phase II for Diabetic Macular Edema. According to GlobalData, Phase II drugs for Diabetic Macular Edema have a 47% phase transition ...
The Sixers dismantled Boston in front of a national audience, sending a clear message: when Embiid is on the floor, the Sixers are legit. The Celtics may have spent the past few seasons thinking they ...